S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10. This evidence concerns the gene ADAM10 and early-onset autosomal dominant Alzheimer disease.